X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2600) 2600
Publication (174) 174
Book Review (47) 47
Book Chapter (13) 13
Dissertation (4) 4
Magazine Article (3) 3
Book / eBook (2) 2
Conference Proceeding (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2215) 2215
index medicus (1383) 1383
male (1325) 1325
female (1321) 1321
community-acquired pneumonia (1137) 1137
aged (1062) 1062
middle aged (1050) 1050
infectious diseases (967) 967
adult (930) 930
community-acquired infections - microbiology (854) 854
pneumonia (840) 840
aged, 80 and over (629) 629
microbiology (629) 629
anti-bacterial agents - therapeutic use (566) 566
community-acquired infections - drug therapy (539) 539
community-acquired infections - epidemiology (535) 535
adolescent (489) 489
risk factors (466) 466
diagnosis (452) 452
bacterial pneumonia (445) 445
epidemiology (420) 420
mortality (410) 410
prospective studies (404) 404
antibiotics (384) 384
health aspects (383) 383
community-acquired infections - diagnosis (378) 378
infections (376) 376
adults (348) 348
retrospective studies (335) 335
management (334) 334
pharmacology & pharmacy (310) 310
child (301) 301
research (301) 301
microbial sensitivity tests (293) 293
internal medicine (290) 290
respiratory system (267) 267
anti-bacterial agents - pharmacology (266) 266
child, preschool (266) 266
streptococcus-pneumoniae (264) 264
young adult (262) 262
hospitals (259) 259
urinary tract infections - microbiology (249) 249
prevalence (248) 248
guidelines (242) 242
treatment outcome (242) 242
medicine, general & internal (240) 240
etiology (239) 239
children (238) 238
community-acquired infections (231) 231
infant (231) 231
hospitalization (226) 226
analysis (218) 218
cross infection - microbiology (216) 216
pneumonia, bacterial - microbiology (216) 216
care and treatment (215) 215
prognosis (214) 214
risk-factors (213) 213
infectious disease (212) 212
infection (209) 209
drug resistance, bacterial (196) 196
pneumonia, bacterial - drug therapy (195) 195
bacteria (194) 194
immunology (193) 193
severity of illness index (179) 179
medicine & public health (177) 177
streptococcus pneumoniae (176) 176
sepsis (170) 170
urinary tract infections (170) 170
antimicrobial resistance (168) 168
medicine (168) 168
incidence (166) 166
bacteremia (165) 165
pathogens (165) 165
cross infection - epidemiology (160) 160
urinary tract infections - drug therapy (160) 160
nosocomial infections (159) 159
pneumonia, bacterial - diagnosis (157) 157
therapy (157) 157
drug resistance in microorganisms (156) 156
sensitivity and specificity (156) 156
streptococcus infections (153) 153
research article (151) 151
drug resistance (149) 149
streptococcus pneumoniae - isolation & purification (146) 146
disease (143) 143
antigens, bacterial - urine (141) 141
escherichia coli infections - microbiology (141) 141
pediatrics (141) 141
resistance (137) 137
polymerase chain reaction (136) 136
staphylococcus aureus (136) 136
patients (134) 134
community-acquired infections - mortality (132) 132
united-states (132) 132
surveillance (131) 131
drug therapy (130) 130
respiratory-tract infections (130) 130
urine (130) 130
urinary tract infections - epidemiology (127) 127
anti-bacterial agents - administration & dosage (126) 126
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2473) 2473
Spanish (55) 55
French (41) 41
German (13) 13
Portuguese (7) 7
Turkish (6) 6
Russian (5) 5
Chinese (3) 3
Dutch (3) 3
Hebrew (3) 3
Japanese (3) 3
Korean (3) 3
Bosnian (2) 2
Italian (2) 2
Polish (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Infection, ISSN 0300-8126, 8/2011, Volume 39, Issue 4, pp. 333 - 340
Extended-spectrum β-lactamases (ESBLs) are an increasing challenge in the treatment of urinary tract infections (UTIs), and also in the community. We aimed to... 
Medicine & Public Health | Nitrofurantoin | Community-acquired urinary tract infection | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Extended-spectrum β-lactamases (ESBLs) | Fosfomycin | INFECTIOUS DISEASES | Extended-spectrum beta-lactamases (ESBLs) | RISK-FACTORS | ACUTE UNCOMPLICATED CYSTITIS | ESCHERICHIA-COLI | NONHOSPITALIZED PATIENTS | RESISTANCE | SWITZERLAND | KLEBSIELLA-PNEUMONIAE | EPIDEMIOLOGY | ENTEROBACTERIACEAE | beta-Lactam Resistance | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Incidence | Anti-Bacterial Agents - therapeutic use | beta-Lactamases - urine | Community-Acquired Infections - drug therapy | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Community-Acquired Infections - urine | Risk Factors | Escherichia coli Infections - microbiology | Treatment Outcome | Urinary Tract Infections - drug therapy | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Analysis of Variance | Escherichia coli - isolation & purification | Switzerland - epidemiology | Escherichia coli Infections - urine | Aged | Anti-Bacterial Agents - pharmacology | Urinary Tract Infections - urine
Journal Article
Chest, ISSN 0012-3692, 06/2017, Volume 151, Issue 6, pp. 1311 - 1319
Journal Article
Journal Article
Journal Article
BMC Infectious Diseases [E], ISSN 1471-2334, 02/2015, Volume 15, Issue 1, pp. 56 - 56
Journal Article
Journal Article
Travel Medicine and Infectious Disease, ISSN 1477-8939, 03/2018, Volume 22, pp. 46 - 50
The epidemiology of extended-spectrum β-lactamase (ESBL)-producing bacteria is fast evolving with increasing global trend towards community-acquired... 
ESBL | Community-acquired | UTI | Escherichia coli | Klebsiella pneumoniae | ANTIMICROBIAL SUSCEPTIBILITY | MOLECULAR CHARACTERIZATION | INFECTIOUS DISEASES | RISK-FACTORS | PREVALENCE | ESCHERICHIA-COLI STRAINS | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | BACTEREMIA | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | EPIDEMIOLOGY | ENTEROBACTERIACEAE | beta-Lactam Resistance | Klebsiella pneumoniae - drug effects | Prevalence | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Middle Aged | Male | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Community-Acquired Infections - drug therapy | Drug Resistance, Multiple, Bacterial | Klebsiella pneumoniae - physiology | Aged, 80 and over | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Escherichia coli - physiology | United Arab Emirates - epidemiology | Escherichia coli - enzymology | Community-Acquired Infections - urine | Risk Factors | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Klebsiella pneumoniae - enzymology | Aged | Urinary Tract Infections - urine | Community-Acquired Infections - microbiology | Health care | Therapy | Laboratories | Education establishments | Organisms | Infections | Gender | Multivariate analysis | Epidemiology | Risk factors | Risks | Ethics | Pain | E coli | Bacteria | Urinary tract infections | Urogenital system | Urine | Enzymes | Automation | Antimicrobial agents | Regression analysis | Patients | Fever | Urinary tract diseases | Studies | Antibiotics | Diabetes | Community
Journal Article
Journal Article
Korean Journal of Internal Medicine, ISSN 1226-3303, 01/2016, Volume 31, Issue 1, pp. 145 - 155
Background/Aims: Efforts to decrease the use of extended-spectrum cephalosporins are required to prevent the selection and transmission of multi-drug resistant... 
Cefuroxime | Escherichia coli | Acute pyelonephritis | MEDICINE, GENERAL & INTERNAL | URINARY-TRACT-INFECTIONS | INVITRO | FLUOROQUINOLONE RESISTANCE | SPECTRUM BETA-LACTAMASES | ACUTE UNCOMPLICATED PYELONEPHRITIS | UPDATE | CEPHALOSPORIN | Community-Acquired Infections - diagnosis | Cefuroxime - adverse effects | Urinalysis | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Pyelonephritis - microbiology | Cefuroxime - therapeutic use | Pyelonephritis - urine | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Time Factors | Community-Acquired Infections - drug therapy | Female | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - adverse effects | Cefuroxime - administration & dosage | Pyelonephritis - diagnosis | Retrospective Studies | Pyelonephritis - drug therapy | Urine - microbiology | Databases, Factual | Escherichia coli Infections - drug therapy | Escherichia coli Infections - diagnosis | Urinary Tract Infections - diagnosis | Community-Acquired Infections - urine | Escherichia coli Infections - microbiology | Treatment Outcome | Hospitalization | Remission Induction | Urinary Tract Infections - drug therapy | Administration, Intravenous | Escherichia coli - isolation & purification | Escherichia coli Infections - urine | Aged | Urinary Tract Infections - urine | Anti-Bacterial Agents - administration & dosage | Community-Acquired Infections - microbiology | Original | 내과학
Journal Article
Journal Article